Childhood brain cancer research breakthrough could transform treatment: International study: Atlanta, Georgia Thursday, February 6, 2025, 14:00 Hrs [IST] Brain cancer is the secon ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

DMG usually occurs in the brainstem, where it is also known as diffuse intrinsic pontine glioma (DIPG). Median overall survival is 11 months for people with DIPG, and 14 months for those with DMG ...

One key initiative includes the establishment of a clinical trial consortium. The Australian Government is set to invest ...

Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a ...

Children struck down with brain cancer have been given new hope with Queensland scientists hailing a breakthrough in the ...

Scientists at The Hospital for Sick Children (SickKids) have discovered a way to prevent tumour growth in a subtype of ...

A new study reveals that the experimental drug CT-179 targets OLIG2-positive cancer stem cells, preventing tumor recurrence in medulloblastoma. Preclinical trials show the drug crosses the blood-brain ...

A medical researcher who has dedicated his career to tackling the deadliest cancers affecting Australian children has ...

leveraging clinical data from a first-in-human Phase 1 trial published today in Nature Medicine BCB-276 uses repetitive intracerebroventricular dosing to treat diffuse intrinsic pontine glioma ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been awarded a $300,000 G-Rex® Grant. The G-Rex® Grant will ...